Transgenic animals and the study of cancer.

Please use this identifier to cite or link to this item: https://scholarbank.nus.edu.sg/handle/10635/112200

DC Field	Value
dc.title	Transgenic animals and the study of cancer.
dc.contributor.author	Murphy, D.
dc.date.accessioned	2014-11-28T02:54:20Z
dc.date.available	2014-11-28T02:54:20Z
dc.date.issued	1993
dc.identifier.citation	Murphy, D. (1993). Transgenic animals and the study of cancer.. Methods in molecular biology (Clifton, N.J.) 18 : 23-36. ScholarBank@NUS Repository.
dc.identifier.issn	19406029
dc.identifier.uri	http://scholarbank.nus.edu.sg/handle/10635/112200
dc.description.abstract	This chapter seeks to outline the strategies being employed to exploit transgenic mice as a tool in the study of cancer. Rather than catalog the many different oncogene and oncogene-promoter combinations that have been introduced into transgenic mice to elicit tumors, I will concentrate on a single system that epitomizes the general approach. That system, pioneered by Philip Leder of Harvard University, is mammary carcinogenesis induced by oncogene expression directed by the Mouse Mammary Tumor Virus (MMTV) enhancer-promoter.
dc.source	Scopus
dc.type	Review
dc.contributor.department	INSTITUTE OF MOLECULAR & CELL BIOLOGY
dc.description.sourcetitle	Methods in molecular biology (Clifton, N.J.)
dc.description.volume	18
dc.description.page	23-36
dc.identifier.isiut	NOT_IN_WOS
Appears in Collections:	Staff Publications

There are no files associated with this item.

Check